07.20.21
Aker BioMarine, a biotech company and global supplier of krill ingredients, announce that it has hired two scientists for its Human Nutrition team. Katina Handeland, PhD, and Yunpeng Ding, PhD have both joined Aker BioMarine as directors for research and development (R&D). They will be responsible for research within the company’s human health and nutrition department.
“We are thrilled to add such top caliber scientists to our Human Health and Nutrition team,” Tim de Haas, EVP for Human Nutrition at Aker BioMarine, said. “Each of them brings extensive knowledge and experience to the table, elevating our current research efforts as well as new areas for the future.”
Handeland will be working to both design and follow up on pre-clinical and clinical trials for Aker’s human health portfolio, studying the biological effects of krill supplementation and its health benefits. She holds a PhD in Nutrition from University of Bergen, and has extensive experience with innovation projects for medical nutrition. She currently serves as President of the Board for the Norwegian Nutrition Society.
“I am very excited to join the team and to play a part in contributing to better and healthier lives globally,” Handeland said. “In addition to the work currently in progress, I will help support the establishment of potential new product lines and areas of focus.”
Yunpeng Ding holds a PhD in Epidemiology and Biostatistics from the University of Bergen, and has had previous involvement in working with drug development and early phase clinical trials. He most recently worked as a senior statistician for a medical research company in Norway.
“My focus will be on Superba Krill oil and its potential for sports performance, metabolic syndrome, as well as cardiovascular and cognitive health,” Ding said. “Going forward, I foresee adding healthy aging and personalized nutrition to my research, as we expand our efforts to find sustainable solutions to improve public health.”
Both Handeland and Ding are based at Aker BioMarine’s headquarters in Lysaker, Norway.
“We are thrilled to add such top caliber scientists to our Human Health and Nutrition team,” Tim de Haas, EVP for Human Nutrition at Aker BioMarine, said. “Each of them brings extensive knowledge and experience to the table, elevating our current research efforts as well as new areas for the future.”
Handeland will be working to both design and follow up on pre-clinical and clinical trials for Aker’s human health portfolio, studying the biological effects of krill supplementation and its health benefits. She holds a PhD in Nutrition from University of Bergen, and has extensive experience with innovation projects for medical nutrition. She currently serves as President of the Board for the Norwegian Nutrition Society.
“I am very excited to join the team and to play a part in contributing to better and healthier lives globally,” Handeland said. “In addition to the work currently in progress, I will help support the establishment of potential new product lines and areas of focus.”
Yunpeng Ding holds a PhD in Epidemiology and Biostatistics from the University of Bergen, and has had previous involvement in working with drug development and early phase clinical trials. He most recently worked as a senior statistician for a medical research company in Norway.
“My focus will be on Superba Krill oil and its potential for sports performance, metabolic syndrome, as well as cardiovascular and cognitive health,” Ding said. “Going forward, I foresee adding healthy aging and personalized nutrition to my research, as we expand our efforts to find sustainable solutions to improve public health.”
Both Handeland and Ding are based at Aker BioMarine’s headquarters in Lysaker, Norway.
